Frontiers in Lipid Lowering Therapy: To Statins and Beyond

“Best medical treatment” are the bywords in the management of peripheral arterial disease (PAD), with lipid lowering therapy (LLT) prescribed de rigueur for arteriopaths. Typical LLT options comprise statins (more accurately, “vastatins”), which are effective in reducing all lipid profile fr actions, including triglycerides (TGs) and low density lipoprotein-cholesterol (LDL-C), where attention is focused.1,2 Statins represent a change from prior yet complementary LLT such as fibrates,3 and gut absorption inhibitors like ezetimibe.
Source: European Journal of Vascular and Endovascular Surgery - Category: Surgery Authors: Tags: Editorial Source Type: research